Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography
Clicks: 318
ID: 10571
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
70.0
/100
318 views
245 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #3 of 25 articles by views in international journal of hepatology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background and Study Aims. Patients undergoing therapeutic endoscopic retrograde cholangiography (ERC) may require different amounts of sedative agents depending on demographic characteristics, indication of ERC, and/or endoscopic intervention. Patients and Methods. We retrospectively analyzed all patients undergoing therapeutic ERC from 2008 – 2014 who received deep sedation with propofol ± midazolam. Results. A total of 2448 ERC procedures were performed in 781 patients. The cumulative per procedure propofol dose in the different groups was as follows: PSC 479 mg (±256), bile duct stones 356 mg (±187), benign stenosis/cholestasis 395 mg (±228), malignant stenosis 401 mg (±283), and postliver transplant complications 391 mg (±223) (p < 0.05). Multivariable analysis showed that dilatation therapy
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (109 words).
Try re-searching for a better abstract.
| Reference Key |
a2019dilatationinternational
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Schmidt, Christoph A.;Keil, Carsten;Kirstein, Martha M.;Lehner, Frank;Manns, Michael P.;von Hahn, Thomas;Lankisch, Tim O.;Voigtländer, Torsten;Schmidt, Christoph A.;Keil, Carsten;Kirstein, Martha M.;Lehner, Frank;Manns, Michael P.;von Hahn, Thomas;Lankisch, Tim O.;Voigtländer, Torsten; |
| Journal | international journal of hepatology |
| Year | 2019 |
| DOI |
10.1155/2019/4793096
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.